These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 8739546

  • 1. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.
    Mansbach RS, Rovetti CC, Winston EN, Lowe JA.
    Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M, Panlilio LV, Antoniou K, Pappas LA, Goldberg SR.
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [Abstract] [Full Text] [Related]

  • 5. Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited.
    Järbe TU, Andrzejewski ME, DiPatrizio NV.
    Pharmacol Biochem Behav; 2002 Nov; 73(4):911-9. PubMed ID: 12213538
    [Abstract] [Full Text] [Related]

  • 6. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR.
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
    McMahon LR, Ginsburg BC, Lamb RJ.
    Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
    Järbe TU, Lamb RJ, Lin S, Makriyannis A.
    Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
    [Abstract] [Full Text] [Related]

  • 10. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ, Crim JL, Darmani NA.
    Pharmacol Biochem Behav; 2002 Aug; 71(1-2):155-62. PubMed ID: 11812518
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
    Darmani NA.
    Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.
    Wiley JL, Matthew Walentiny D, Vann RE, Baskfield CY.
    Behav Pharmacol; 2011 Sep; 22(5-6):480-8. PubMed ID: 21712709
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats.
    Malone DT, Taylor DA.
    Behav Brain Res; 2006 Jan 06; 166(1):101-9. PubMed ID: 16143410
    [Abstract] [Full Text] [Related]

  • 20. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM, Wakley AA, Tsutsui KT, Laggart JD.
    J Pharmacol Exp Ther; 2012 Mar 06; 340(3):787-800. PubMed ID: 22182934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.